{"id":241712,"date":"2024-07-08T09:01:10","date_gmt":"2024-07-08T09:01:10","guid":{"rendered":"https:\/\/www.clarivate.com.cn\/?p=241712"},"modified":"2026-03-12T08:28:13","modified_gmt":"2026-03-12T08:28:13","slug":"perceptions-of-pharmaceutical-industry-affiliates-on-the-new-active-substance-work-sharing-initiative-of-the-access-consortium","status":"publish","type":"post","link":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/blog\/perceptions-of-pharmaceutical-industry-affiliates-on-the-new-active-substance-work-sharing-initiative-of-the-access-consortium\/","title":{"rendered":"Access \u8054\u76df\u65b0\u6d3b\u6027\u7269\u8d28\u5de5\u4f5c\u5171\u4eab\u8ba1\u5212\uff1a\u5236\u836f\u884c\u4e1a\u5173\u8054\u65b9\u770b\u6cd5"},"content":{"rendered":"<p>\u65b0\u6d3b\u6027\u7269\u8d28\u5de5\u4f5c\u5171\u4eab\u8ba1\u5212 (NASWSI)\uff0c\u7b80\u79f0\u201cAccess\u201d\uff0c\u5141\u8bb8 Access \u8054\u76df\uff08\u6fb3\u5927\u5229\u4e9a\u3001\u52a0\u62ff\u5927\u3001\u65b0\u52a0\u5761\u3001\u745e\u58eb\u548c\u82f1\u56fd\uff09\u6210\u5458\u56fd\u7684\u76d1\u7ba1\u673a\u6784 (Regulatory Authority\uff0cRA) \u5bf9\u65b0\u6d3b\u6027\u7269\u8d28\u6216\u65b0\u9002\u5e94\u75c7\u7684\u6ce8\u518c\u7533\u8bf7\u8fdb\u884c\u8054\u5408\u5ba1\u8bc4\u3002Access \u8054\u76df\u662f\u7531\u4e2d\u7b49\u89c4\u6a21 RA \u7ec4\u6210\u7684\u8054\u76df\uff0c\u65e8\u5728\u901a\u8fc7\u5408\u4f5c\u548c\u5de5\u4f5c\u5171\u4eab\uff0c\u6700\u5927\u9650\u5ea6\u5730\u63d0\u9ad8\u56fd\u9645\u5408\u4f5c\uff0c\u51cf\u5c11\u91cd\u590d\u5de5\u4f5c\uff0c\u5e76\u63d0\u9ad8 RA \u786e\u4fdd\u53ca\u65f6\u83b7\u5f97\u9ad8\u8d28\u91cf\u3001\u5b89\u5168\u6709\u6548\u6cbb\u7597\u4ea7\u54c1\u7684\u80fd\u529b\u3002\u6bcf\u4e2a RA \u90fd\u4fdd\u7559\u505a\u51fa\u6700\u7ec8\u51b3\u5b9a\u7684\u6743\u529b\u3002<\/p>\n<p>2022 \u5e74\u5e95\uff0cAccess \u8054\u76df\u56fd\u5bb6\u7684\u5236\u836f\u884c\u4e1a\u534f\u4f1a\u5bf9\u5176\u6210\u5458\u56fd\u7684\u884c\u4e1a\u5173\u8054\u65b9\u53d1\u8d77\u4e86\u4e00\u9879\u8c03\u67e5\uff0c\u4ee5\u4e86\u89e3\u4e1a\u754c\u5bf9 Access \u7684\u770b\u6cd5\u3002\u8c03\u67e5\u83b7\u5f97\u4e86 66% (108\/164) \u7684\u56de\u590d\u7387\uff08\u5177\u4f53\u800c\u8a00\uff0c41 \u5bb6\u53d7\u8bbf\u516c\u53f8\u5df2\u53c2\u4e0eAccess\uff0c\u800c 67 \u5bb6\u53d7\u8bbf\u516c\u53f8\u5c1a\u672a\u53c2\u4e0e\uff09\u3002<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-241713 size-full\" src=\"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2025\/01\/perceptions_of_pharmaceutical_industry_picture7.png\" alt=\"\u79d1\u777f\u552f\u5b89_\u533b\u836f\u6570\u636e\u4ea7\u54c1\u516c\u53f8_\u533b\u836f\u6570\u636e\u5e93\" width=\"602\" height=\"276\" srcset=\"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2025\/01\/perceptions_of_pharmaceutical_industry_picture7.png 602w, https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2025\/01\/perceptions_of_pharmaceutical_industry_picture7-300x138.png 300w, https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2025\/01\/perceptions_of_pharmaceutical_industry_picture7-87x40.png 87w\" sizes=\"auto, (max-width: 602px) 100vw, 602px\" \/><\/p>\n<p>\u672c\u9879\u76ee\u7531\u82f1\u56fd\u5236\u836f\u5de5\u4e1a\u534f\u4f1a (ABPI) \u7275\u5934\u3002\u79d1\u777f\u552f\u5b89\u4e0e ABPI \u6210\u5458\u548c\u5176\u4ed6\u884c\u4e1a\u534f\u4f1a\u5408\u4f5c\uff0c\u5bf9\u8c03\u67e5\u7ed3\u679c\u8fdb\u884c\u4e86\u5206\u6790\uff0c\u5e76\u5171\u540c\u64b0\u5199\u4e86\u4e00\u7bc7\u540c\u884c\u8bc4\u5ba1\u7a3f\u4ef6\uff08\u5df2\u4e8e 2024 \u5e74 3 \u6708\u5728 <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s43441-024-00624-7\" target=\"_blank\" rel=\"noopener\">TIRS (DIA)<\/a> \u671f\u520a\u53d1\u8868\uff09\u3002<\/p>\n<p>\u9274\u4e8e\u901a\u8fc7 Access \u63d0\u4ea4\u76d1\u7ba1\u6587\u4ef6\u5e76\u975e\u5f3a\u5236\u6027\u8981\u6c42\uff0c\u56e0\u6b64\u4e86\u89e3\u4e1a\u754c\u5bf9 Access \u7684\u770b\u6cd5\u5bf9\u4e8e\u5982\u4f55\u52a0\u5f3a\u8be5\u5021\u8bae\u7684\u653f\u7b56\u8ba8\u8bba\u81f3\u5173\u91cd\u8981\u3002<\/p>\n<h3>\u5236\u836f\u884c\u4e1a\u5173\u8054\u65b9\u5927\u591a\u5bf9 Access \u8868\u793a\u80af\u5b9a<\/h3>\n<p>\u5927\u591a\u6570\u53c2\u4e0e Access \u7684\u5173\u8054\u65b9\u90fd\u5bf9\u8be5\u5021\u8bae\u7684\u5404\u4e2a\u9636\u6bb5\u8868\u793a\u6709\u826f\u597d\u7684\u4f53\u9a8c\u3002\u5173\u8054\u65b9\u4e3b\u8981\u62a5\u544a\u79f0\u4e0e RA \u7684\u6c9f\u901a\u4ea4\u6d41\u79ef\u6781\u6b63\u9762\uff0c\u5e76\u5728\u9884\u8bbe\u65f6\u95f4\u8282\u70b9\u6536\u5230\u6c47\u603b\u95ee\u9898\u6e05\u5355\u3002\u4f46\u5173\u8054\u65b9\u4e5f\u6307\u51fa\u4e86\u4e00\u4e9b\u6311\u6218\uff0c\u4f8b\u5982\u6536\u5230\u6eda\u52a8\u63d0\u95ee\uff0c\u8fd9\u52a0\u5927\u4e86\u8d44\u6e90\u89c4\u5212\u7684\u96be\u5ea6\u3002<\/p>\n<p>\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u5173\u8054\u65b9\u62a5\u544a\u7684\u4f53\u9a8c\u5dee\u5f02\u53ef\u80fd\u662f\u7531\u4e8e\u4ed6\u4eec\u53c2\u4e0e\u4e86\u4e0d\u540c\u7684 Access \u5ba1\u67e5\uff08\u80cc\u666f\u4e0d\u540c\uff09\uff0c\u4e5f\u53ef\u80fd\u662f\u7531\u4e8e\u4ed6\u4eec\u53c2\u4e0e\u8be5\u6d41\u7a0b\u7684\u65f6\u95f4\u4e0d\u540c\u3002\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0cAccess \u4f3c\u4e4e\u671d\u7740\u66f4\u597d\u7684\u65b9\u5411\u53d1\u5c55\uff0c\u6b63\u5982\u5173\u8054\u65b9\u62a5\u544a\u79f0\uff0c\u4e0e\u8be5\u5021\u8bae\u7684\u65e9\u671f\u9636\u6bb5\u76f8\u6bd4\uff0c\u8fd1\u5e74\u6765\u7684\u6307\u5357\u66f4\u52a0\u6e05\u6670\u3002<\/p>\n<p>\u6709\u8da3\u7684\u662f\uff0c\u6839\u636e\u5927\u591a\u6570\uff0880%\uff09\u53c2\u4e0e Access \u7684\u5173\u8054\u65b9\u53cd\u9988\uff0c\u901a\u8fc7 Access \u83b7\u5f97\u6279\u51c6\u5bf9\u5176\u6240\u5728\u56fd\u5bb6\u7684\u5b9a\u4ef7\u548c\u62a5\u9500\u65f6\u95f4\u8868\u201c\u65e0\u5f71\u54cd\u201d\uff0c\u8fd9\u8868\u660e\u9700\u8981\u4ed8\u51fa\u66f4\u591a\u52aa\u529b\uff0c\u4ee5\u786e\u4fdd\u8f83\u65e9\u76d1\u7ba1\u6279\u51c6\u5e26\u6765\u7684\u6536\u76ca\u80fd\u591f\u8f6c\u5316\u4e3a\u56fd\u5bb6\u5c42\u9762\u4e0a\u7684\u52a0\u5feb\u51c6\u5165\u3002Access \u8054\u76df 2021-2024 \u5e74\u6218\u7565\u8ba1\u5212\u7684\u6218\u7565\u76ee\u6807\u662f\u63a2\u7d22\u4e0e\u56fd\u5bb6\u536b\u751f\u6280\u672f\u8bc4\u4f30\uff08Health Technology Assessment\uff0cHTA\uff09\u673a\u6784\u7684\u5408\u4f5c\uff0c\u56e0\u6b64\u672a\u6765\u6216\u5c06\u5728\u8be5\u9886\u57df\u53d6\u5f97\u8fdb\u5c55\u3002<\/p>\n<h3>\u610f\u8bc6\u5230\u7684\u53c2\u4e0e\u969c\u788d\u4f9d\u7136\u5b58\u5728<\/h3>\n<p>\u884c\u4e1a\u5173\u8054\u65b9\u4e0d\u53c2\u4e0e Access \u7684\u539f\u56e0\uff08\u53ef\u901a\u8fc7\u591a\u9879\u9009\u62e9\u9898\u63d0\u4f9b\u591a\u4e2a\u539f\u56e0\uff09\u5305\u62ec RA \u4e4b\u95f4\u505a\u51fa\u4e0d\u540c\u51b3\u5b9a\u7684\u98ce\u9669\uff0839%\uff09\u3001\u6d41\u7a0b\u8fc7\u4e8e\u590d\u6742\u96be\u4ee5\u7ba1\u7406\uff0837%\uff09\u4ee5\u53ca\u5404\u56fd\u8981\u6c42\u548c\u5ba1\u67e5\u5b9e\u8df5\u7684\u5dee\u5f02\uff0836%\uff09\u3002<\/p>\n<p>\u7f3a\u4e4f\u76f8\u5173\u6d41\u7a0b\u7684\u7ecf\u9a8c\u4e5f\u662f\u5173\u8054\u65b9\u4e0d\u53c2\u4e0e\u7684\u539f\u56e0\u4e4b\u4e00\u3002\u8c03\u67e5\u7ed3\u679c\u8868\u660e\uff0c\u5173\u8054\u65b9\u53c2\u4e0e Access \u7684\u6b21\u6570\u6108\u591a\uff0c\u5176\u5bf9 Access \u6d41\u7a0b\u5c31\u6108\u52a0\u4e60\u60ef\uff0c\u4ece\u9996\u6b21\u63d0\u4ea4\u540e\u5bf9\u63d0\u4ea4\u524d\u7269\u6d41\u4f1a\u8bae\u7684\u9700\u6c42\u51cf\u5c11\u5c31\u53ef\u4ee5\u770b\u51fa\u8fd9\u4e00\u70b9\u3002<\/p>\n<h3>Access \u6301\u7eed\u6539\u8fdb\u7684\u5951\u673a<\/h3>\n<p>\u8c03\u67e5\u63d0\u51fa\u7684\u5efa\u8bae\u5206\u4e3a\u516d\u4e2a\u65b9\u9762\uff1a\u786e\u4fdd\u53ef\u9884\u6d4b\u6027\uff08\u5305\u62ec\u9075\u5faa\u65f6\u95f4\u8868\u3001\u907f\u514d\u6eda\u52a8\u95ee\u9898\u4ee5\u53ca\u4e89\u53d6\u6bd4\u56fd\u5bb6\u9014\u5f84\u66f4\u77ed\u7684\u5ba1\u67e5\u65f6\u95f4\u8868\uff09\u3001\u63d0\u9ad8\u6307\u5bfc\u548c\u900f\u660e\u5ea6\u3001\u7b80\u5316\u6d41\u7a0b\u3001\u4fdd\u6301\u7075\u6d3b\u6027\u3001\u52a0\u5f3a\u534f\u8c03\u6027\uff08\u7279\u522b\u662f\u5bf9\u4e8e\u4f18\u5148\u5ba1\u8bc4\u8bf7\u6c42\uff09\u4ee5\u53ca\u63a8\u8fdb\u884c\u4e1a\u4e0e RA \u4e4b\u95f4\u7684\u5408\u4f5c\u3002<\/p>\n<p>\u5c3d\u7ba1 Access \u5e76\u4e0d\u65e8\u5728\u63d0\u4f9b\u52a0\u901f\u5ba1\u67e5\u65f6\u95f4\u8868\uff0c\u800c\u662f\u4fc3\u8fdb\u8d44\u6e90\u7684\u6709\u6548\u5229\u7528\uff0c\u4f46\u5173\u8054\u65b9\u53ef\u80fd\u4ecd\u7136\u671f\u671b\u901a\u8fc7 Access \u5b9e\u73b0\u66f4\u77ed\u7684\u5ba1\u67e5\u65f6\u95f4\u8868\u3002\u4e0e\u6807\u51c6\u7684\u56fd\u5bb6\u5ba1\u67e5\u76f8\u6bd4\uff0cRA \u5b9e\u9645\u4e0a\u53ef\u80fd\u88ab\u8ba4\u4e3a\u5728 Access \u5408\u4f5c\u5ba1\u67e5\u4e2d\u7684\u5de5\u4f5c\u91cf\u66f4\u5c11\u3002<\/p>\n<p>\u8f83\u597d\u7684\u662f\uff0c\u65e9\u5728\u884c\u4e1a\u8c03\u67e5\u7ed3\u679c\u516c\u5e03\u4e4b\u524d\uff0c\u5c31\u5df2\u7ecf\u91c7\u53d6\u4e86\u52a0\u5f3a Access \u7684\u5177\u4f53\u63aa\u65bd\u3002\u4f8b\u5982\uff0c2023 \u5e74 12 \u6708\u5ba3\u5e03\u7684\u201c\u627f\u8bfa\u8bd5\u70b9\u9014\u5f84\u201d\u4e3a\u4f18\u5148\u5ba1\u8bc4\u8bf7\u6c42\u63d0\u4f9b\u4e86\u4e00\u4e2a\u66f4\u4e3a\u534f\u8c03\u7684\u6d41\u7a0b\uff0c\u5305\u62ec RA \u4e4b\u95f4\u7684\u534f\u4f5c\u8bc4\u4f30\u548c\u5171\u540c\u7684\u65f6\u95f4\u8868\uff08\u800c\u4e0d\u662f\u7531\u5404 RA \u5206\u6790\u4f18\u5148\u5ba1\u8bc4\u8bf7\u6c42\u7684\u8d44\u683c\uff09\u3002\u6b64\u5916\uff0cRA \u4e0e\u516c\u53f8\u4e4b\u95f4\u65b0\u7684\u8054\u5408\u7ba1\u7ebf\u4f1a\u8bae\u5c06\u4fc3\u8fdb\u65b0\u53d1\u5c55\u548c\u66f4\u591a\u5408\u4f5c\u7684\u4fe1\u606f\u4ea4\u6d41\u3002<\/p>\n<p>\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0cAccess \u4f3c\u4e4e\u6b63\u5728\u9010\u6b65\u5b8c\u5584\uff0c\u5c3d\u7ba1\u4ecd\u6709\u673a\u4f1a\u8fdb\u4e00\u6b65\u4f18\u5316\u8be5\u8ba1\u5212\uff0c\u4f46\u7ed3\u679c\u8868\u660e\u8be5\u5021\u8bae\u6301\u7eed\u6709\u6548\uff0c\u5177\u6709\u53d1\u5c55\u524d\u666f\u3002\u79d1\u777f\u552f\u5b89\u7684\u536b\u751f\u653f\u7b56\u54a8\u8be2\u4e13\u5bb6\u4e3a\u5305\u62ec\u8d38\u6613\u534f\u4f1a\u548c\u751f\u7269\u5236\u836f\u516c\u53f8\u5728\u5185\u7684\u4f17\u591a\u5229\u76ca\u76f8\u5173\u8005\u63d0\u4f9b\u652f\u6301\uff0c\u4ee5\u63a8\u52a8\u536b\u751f\u653f\u7b56\u7684\u53d8\u9769\u3002<\/p>\n<p>\u5982\u679c\u60a8\u60f3\u4e0e\u6211\u53f8\u7684\u5546\u4e1a\u6218\u7565\u56e2\u961f\uff08\u5305\u62ec\u536b\u751f\u653f\u7b56\u548c\u5e02\u573a\u51c6\u5165\u4e13\u5bb6\uff09\u8ba8\u8bba\u60a8\u7684\u8ba1\u5212\uff0c\u8bf7<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/consulting-services\/commercial-consulting-services\/\" target=\"_blank\" rel=\"noopener\">\u70b9\u51fb\u6b64\u5904<\/a>\u8054\u7cfb\u6211\u4eec\u3002<\/p>\n<p>\u672c\u6587\u7531\u79d1\u777f\u552f\u5b89\u7684\u536b\u751f\u653f\u7b56\u987e\u95ee Gaia Geraci \u64b0\u5199\u3002Gaia \u4e3a\u5305\u62ec\u8d38\u6613\u534f\u4f1a\u548c\u5404\u79cd\u751f\u7269\u5236\u836f\u516c\u53f8\u5728\u5185\u7684\u4f17\u591a\u5ba2\u6237\u63d0\u4f9b\u652f\u6301\uff0c\u4ee5\u5e2e\u52a9\u4ed6\u4eec\u4e86\u89e3\u653f\u7b56\u73af\u5883\u5e76\u63a8\u52a8\u653f\u7b56\u53d8\u9769\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u65b0\u6d3b\u6027\u7269\u8d28\u5de5\u4f5c\u5171\u4eab\u8ba1\u5212 (NASWSI)\uff0c\u7b80\u79f0\u201cAccess\u201d\uff0c\u5141\u8bb8 Access \u8054\u76df\uff08\u6fb3\u5927\u5229\u4e9a\u3001\u52a0\u62ff\u5927\u3001\u65b0\u52a0\u5761\u3001\u745e\u58eb\u548c\u82f1\u56fd\uff09\u6210\u5458\u56fd\u7684\u76d1\u7ba1\u673a\u6784 (Regulatory Authority\uff0cRA) \u5bf9\u65b0\u6d3b\u6027\u7269\u8d28\u6216\u65b0\u9002\u5e94\u75c7\u7684\u6ce8\u518c\u7533\u8bf7\u8fdb\u884c\u8054\u5408\u5ba1\u8bc4\u3002Access \u8054\u76df\u662f\u7531\u4e2d\u7b49\u89c4\u6a21 RA \u7ec4\u6210\u7684\u8054\u76df\uff0c\u65e8\u5728\u901a\u8fc7\u5408\u4f5c\u548c\u5de5\u4f5c\u5171\u4eab\uff0c\u6700\u5927\u9650\u5ea6\u5730\u63d0\u9ad8\u56fd\u9645\u5408\u4f5c\uff0c\u51cf\u5c11\u91cd\u590d\u5de5\u4f5c\uff0c\u5e76\u63d0\u9ad8 RA \u786e\u4fdd\u53ca\u65f6\u83b7\u5f97\u9ad8\u8d28\u91cf\u3001\u5b89\u5168\u6709\u6548\u6cbb\u7597\u4ea7\u54c1\u7684\u80fd\u529b\u3002\u6bcf\u4e2a RA \u90fd\u4fdd\u7559\u505a\u51fa\u6700\u7ec8\u51b3\u5b9a\u7684\u6743\u529b\u3002 2022 \u5e74\u5e95\uff0cAccess \u8054\u76df\u56fd\u5bb6\u7684\u5236\u836f\u884c\u4e1a\u534f\u4f1a\u5bf9\u5176\u6210\u5458\u56fd\u7684\u884c\u4e1a\u5173\u8054\u65b9\u53d1\u8d77\u4e86\u4e00\u9879\u8c03\u67e5\uff0c\u4ee5\u4e86\u89e3\u4e1a\u754c\u5bf9 Access \u7684\u770b\u6cd5\u3002\u8c03\u67e5\u83b7\u5f97\u4e86 66% (108\/164) \u7684\u56de\u590d\u7387\uff08\u5177\u4f53\u800c\u8a00\uff0c41 \u5bb6\u53d7\u8bbf\u516c\u53f8\u5df2\u53c2\u4e0eAccess\uff0c\u800c 67 \u5bb6\u53d7\u8bbf\u516c\u53f8\u5c1a\u672a\u53c2\u4e0e\uff09\u3002 \u672c\u9879\u76ee\u7531\u82f1\u56fd\u5236\u836f\u5de5\u4e1a\u534f\u4f1a (ABPI) \u7275\u5934\u3002\u79d1\u777f\u552f\u5b89\u4e0e ABPI \u6210\u5458\u548c\u5176\u4ed6\u884c\u4e1a\u534f\u4f1a\u5408\u4f5c\uff0c\u5bf9\u8c03\u67e5\u7ed3\u679c\u8fdb\u884c\u4e86\u5206\u6790\uff0c\u5e76\u5171\u540c\u64b0\u5199\u4e86\u4e00\u7bc7\u540c\u884c\u8bc4\u5ba1\u7a3f\u4ef6\uff08\u5df2\u4e8e&#8230;<\/p>\n","protected":false},"author":6,"featured_media":241726,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[3,44,43],"tags":[69,56],"class_list":["post-241712","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences-healthcare","category-medtech","category-biopharma","tag-market-access","tag-pharmaceutical-regulations","clarivate-industry-life-sciences-and-healthcare"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-20 19:07:23","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/241712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=241712"}],"version-history":[{"count":5,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/241712\/revisions"}],"predecessor-version":[{"id":435856,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/241712\/revisions\/435856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/241726"}],"wp:attachment":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=241712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=241712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=241712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}